Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
RTK Group, LLC is a biopharmaceutical advisory and investment fund founded in December 2019. Based in Boston, Massachusetts, the firm focuses on supporting companies that develop technologies with disruptive potential to benefit patients. The organization leverages its expertise in company formation and technology development to assist management teams in realizing the full value of their innovations.
As of now, RTK Group manages a portfolio of four companies and operates as a family office, indicating a more personalized investment approach. The firm is actively involved in the healthcare sector, particularly in biotechnology, pharmaceuticals, medical devices, and diagnostics. Notable milestones include joining the Massachusetts Biotechnology Council in January 2023, which enhances its engagement within the biotech community.
RTK Group invests in emerging technologies within the healthcare sector, specifically targeting biotechnology, pharmaceuticals, medical devices, and diagnostics. The firm supports companies at various stages of their lifecycle, including pre-seed, seed, seed-plus, Series A, Series B, Series C, growth equity, and IPO. This broad stage focus allows RTK Group to engage with startups from their inception through to public offerings.
The organization embraces scientific risk and aims to accelerate disruptive innovations that have significant potential to improve patient lives. RTK Group combines capital with advisory services, providing strategic guidance to management teams navigating the complexities of bringing innovative healthcare solutions to market. The firm looks for founders who demonstrate a strong vision and commitment to advancing healthcare technologies.
RTK Group's portfolio includes four notable companies:
These companies exemplify RTK Group's commitment to investing in innovative solutions that address significant healthcare challenges.
Teena Kohli, MD, MS - Founding Partner. Teena has a background in medicine and has been instrumental in establishing RTK Group's strategic direction.
Neal I. Muni, MD, MSPH - Managing Director. Neal brings extensive experience in public health and biopharmaceuticals, contributing to the firm's investment decisions and portfolio management.
To pitch RTK Group, founders should send an email to info@rtkgrp.com. It is important to include a comprehensive pitch deck that outlines the business model, technology, market opportunity, and team qualifications. While there is no specific application form, a well-structured email will facilitate the review process. Founders can expect a response within a few weeks, depending on the volume of inquiries.
In June 2022, RTK Group participated in the seed-round capital funding for Unravel Biosciences, a Harvard Wyss Institute spinout focused on CNS diseases. The deal size was undisclosed.
In January 2023, RTK Group joined the Massachusetts Biotechnology Council, indicating a commitment to deeper involvement in the biotech community.
What are RTK Group's investment criteria?
RTK Group invests in early-stage and late-stage companies within the healthcare sector, specifically in biotechnology, pharmaceuticals, medical devices, and diagnostics. They focus on disruptive technologies that have the potential to significantly improve patient outcomes.
How can I apply or pitch to RTK Group?
Founders can pitch to RTK Group by sending an email to info@rtkgrp.com. It is advisable to include a detailed overview of the business, the technology being developed, and the potential market impact.
What makes RTK Group different from other investors?
RTK Group combines capital investment with strategic advisory services, leveraging their expertise in biopharmaceuticals and technology development to support management teams throughout the lifecycle of their innovations.
What is RTK Group's geographic focus?
RTK Group primarily invests in companies based in North America, allowing them to closely monitor and support their portfolio companies.
What is the typical check size for investments?
While specific check sizes are not disclosed, RTK Group invests across various stages, indicating flexibility in funding amounts based on the needs of the portfolio companies.
What is RTK Group's post-investment involvement?
RTK Group provides ongoing strategic advisory services to its portfolio companies, assisting them in navigating the complexities of the healthcare market and maximizing the value of their innovations.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.